Efalizumab for Eczema
NCT00146003
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Dermatitis, Atopic
Interventions
DRUG:
Efalizumab treatment
Sponsor
University of Medicine and Dentistry of New Jersey
Collaborators
[object Object]